DK441987A - Farmaceutisk praeparat til behandling af cerebral ischaemi - Google Patents

Farmaceutisk praeparat til behandling af cerebral ischaemi

Info

Publication number
DK441987A
DK441987A DK441987A DK441987A DK441987A DK 441987 A DK441987 A DK 441987A DK 441987 A DK441987 A DK 441987A DK 441987 A DK441987 A DK 441987A DK 441987 A DK441987 A DK 441987A
Authority
DK
Denmark
Prior art keywords
ischaemi
cerebral
treatment
pharmaceutical preparation
pharmaceutical
Prior art date
Application number
DK441987A
Other languages
English (en)
Other versions
DK441987D0 (da
DK171392B1 (da
Inventor
Yukifumi Noda
Hiroyuki Nabata
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of DK441987D0 publication Critical patent/DK441987D0/da
Publication of DK441987A publication Critical patent/DK441987A/da
Application granted granted Critical
Publication of DK171392B1 publication Critical patent/DK171392B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
DK441987A 1986-08-27 1987-08-25 Anvendelse af N-(2-hydroxyethyl)nicotinamidnitrat eller et farmaceutisk acceptabelt salt deraf til fremstilling af et farmaceutisk præparat til forøgelse af hjernens glucoseoptagelse DK171392B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP19879686 1986-08-27
JP19879686 1986-08-27

Publications (3)

Publication Number Publication Date
DK441987D0 DK441987D0 (da) 1987-08-25
DK441987A true DK441987A (da) 1988-02-28
DK171392B1 DK171392B1 (da) 1996-10-14

Family

ID=16397046

Family Applications (1)

Application Number Title Priority Date Filing Date
DK441987A DK171392B1 (da) 1986-08-27 1987-08-25 Anvendelse af N-(2-hydroxyethyl)nicotinamidnitrat eller et farmaceutisk acceptabelt salt deraf til fremstilling af et farmaceutisk præparat til forøgelse af hjernens glucoseoptagelse

Country Status (22)

Country Link
US (1) US4870090A (da)
JP (1) JPH07121863B2 (da)
KR (1) KR950002151B1 (da)
AU (1) AU603375B2 (da)
BE (1) BE1003959A5 (da)
CA (1) CA1302888C (da)
CH (1) CH672069A5 (da)
DE (1) DE3728499A1 (da)
DK (1) DK171392B1 (da)
FI (1) FI873727L (da)
FR (1) FR2605222B1 (da)
GB (1) GB2195532B (da)
HK (1) HK64993A (da)
IE (1) IE60601B1 (da)
IT (1) IT1211477B (da)
LU (1) LU86973A1 (da)
NL (1) NL8701994A (da)
NO (1) NO873571L (da)
NZ (1) NZ221564A (da)
SE (1) SE502323C2 (da)
SG (1) SG52393G (da)
ZA (1) ZA876401B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736529A (en) * 1996-03-22 1998-04-07 Neurocal International Inc. Use of NAD-related compounds in the treatment of neural trauma to inhibit neurodegeneration
WO1999020284A1 (en) * 1997-10-23 1999-04-29 Trustees Of The University Of Pennsylvania Methods for reducing ischemic injury of the heart via the sequential administration of monophosphoryl lipid a and adenosine receptor agents
AU4841700A (en) 1999-05-12 2000-11-21 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
CN107773545A (zh) * 2016-08-29 2018-03-09 烟台益诺依生物医药科技有限公司 依达拉奉与(+)‑2‑莰醇的舌下用药物组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200640A (en) * 1976-04-02 1980-04-29 Chugai Seiyaku Kabushiki Kaisha Nitric ester of N-(2-hydroxyethyl)nicotinamide and pharmaceutical use
GB1562962A (en) * 1976-04-02 1980-03-19 Chugai Pharmaceutical Co Ltd Nicotinamide derivatives processes for producting the same and pharmaceutical compositions containing the same
WO1986006960A2 (en) * 1985-05-22 1986-12-04 Beecham Group P.L.C. Use of nicorandil or pinacidil for the treatment of peripheral vascular disease
US4696934A (en) * 1986-01-10 1987-09-29 Warner-Lambert Company Method for using nifedipine for treating stroke
EP0259309A1 (en) * 1986-03-14 1988-03-16 Medical College Of Wisconsin Research Foundation, Inc. Method of treatment and prevention of cerebral vasospasms

Also Published As

Publication number Publication date
NO873571D0 (no) 1987-08-24
CH672069A5 (da) 1989-10-31
GB8720219D0 (en) 1987-10-07
LU86973A1 (fr) 1987-12-16
FI873727A7 (fi) 1988-02-28
IT8767725A0 (it) 1987-08-21
JPS63152317A (ja) 1988-06-24
NZ221564A (en) 1999-08-30
SE8703308L (sv) 1988-02-28
FR2605222A1 (fr) 1988-04-22
KR880002525A (ko) 1988-05-09
IT1211477B (it) 1989-11-03
AU7731187A (en) 1988-03-03
SE502323C2 (sv) 1995-10-02
DE3728499A1 (de) 1988-03-03
SE8703308D0 (sv) 1987-08-26
BE1003959A5 (fr) 1992-07-22
SG52393G (en) 1993-08-06
ZA876401B (en) 1988-04-27
FI873727L (fi) 1988-02-28
HK64993A (en) 1993-07-16
FI873727A0 (fi) 1987-08-27
DK441987D0 (da) 1987-08-25
US4870090A (en) 1989-09-26
FR2605222B1 (fr) 1991-02-22
DK171392B1 (da) 1996-10-14
GB2195532B (en) 1990-05-23
JPH07121863B2 (ja) 1995-12-25
NL8701994A (nl) 1988-03-16
NO873571L (no) 1988-02-29
IE872218L (en) 1988-02-27
CA1302888C (en) 1992-06-09
GB2195532A (en) 1988-04-13
KR950002151B1 (ko) 1995-03-14
AU603375B2 (en) 1990-11-15
IE60601B1 (en) 1994-07-27

Similar Documents

Publication Publication Date Title
DK333788D0 (da) Farmaceutisk praeparat til behandling af oedelagt bruskvaev
DK263288D0 (da) Farmaceutisk praeparat af cefuroxim-axetil
DK99086D0 (da) Farmaceutiske praeparater til behandling af hukommelsesforstyrrelser
DK545088D0 (da) Doseringsform til behandling af kardiovaskulaere sygdomme
DK217188A (da) Farmaceutisk praeparat til behandling af neurologiske sygdomme
DK153387A (da) Fremgangsmaade til fremstilling af laegemiddel-adsorbater
DK254887A (da) Salve til behandling af hudsygdomme
NO872551D0 (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater
DK549087A (da) Gangliosidbeslaegtede forbindelser og fremgangsmaade til fremstilling af samme
DK537687D0 (da) Fremgangsmaade til fremstilling af n-substituerede piperazinoner
NO874200L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater
DK298187D0 (da) Applikator til behandling af laeber
DK87888A (da) Terapeutisk anvendelse af tindijoddeuteroporfyrin
DK0458855T3 (da) Farmaceutisk præparat til behandling af tonsillitis
DK441987D0 (da) Farmaceutisk praeparat til behandling af cerebral ischaemi
DK500589D0 (da) Farmaceutisk praeparat til behandling af lungeobstruktioner
NO875359L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater
NO873423D0 (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater
NO872233D0 (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater
DK72288A (da) Farmaceutisk praeparat til behandling af ulcerativ tyktarmssygdom
DK302887A (da) Anvendelse af tumornecrosefaktor-alfa til fremstilling af antiinfektivt laegemiddel
DK670588D0 (da) Farmaceutisk praeparat til behandling af phlebektasi og fremgangsmaade til fremstilling af praeparatet
DK469487A (da) Laegemiddel til behandling af fedme
DK68790A (da) Anvendelse af tripeptidet l-pyroglutamyl-l-histidylglycin til fremstilling af laegemidler
DK639088D0 (da) Laegemiddel til behandling af iskaemiske hjertesygdomme

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK